Clinical Trial Results: A Clinical Trial to Evaluate the Safety, Efficacy and Immune Responses After Vaccination With an Investigational RNA-based Vaccine Against Malaria [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial results for an investigational RNA-based malaria vaccine assessing safety, efficacy, and immune responses were completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• Investigational RNA-based vaccine against malaria

Snippet

Sponsor: BioNTech SE | Conditions: Malaria | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2026-08-28